Eidos Therapeutics, Inc.

CIK 1731831 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eidos Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 5, 202115-12B0001193125-21-030646
Jan 28, 202140000899243-21-003644
Jan 28, 202140000899243-21-003647
Jan 28, 202140000899243-21-003651
Jan 28, 202140000899243-21-003669
Jan 28, 202140000899243-21-003649
Jan 28, 202140000899243-21-003639
Jan 28, 202140000899243-21-003642
Jan 28, 202140000899243-21-003671
Jan 27, 2021EFFECT9999999995-21-000293
Jan 26, 2021S-8 POS0001193125-21-017697
Jan 26, 2021S-8 POS0001193125-21-017699
Jan 26, 2021POS AM0001193125-21-017696
Jan 26, 2021S-8 POS0001193125-21-017698
Jan 26, 202140000899243-21-003286
Jan 26, 20218-K0001193125-21-017109
Jan 26, 202125-NSE0001354457-21-000105
Jan 26, 2021SC 13D/A0001193125-21-017128
Jan 26, 2021SC 13D/A0001193125-21-017733
Jan 20, 20218-K0001193125-21-012447
Jan 15, 202140000899243-21-002179
Jan 13, 202140000899243-21-001847
Jan 13, 20214250001193125-21-008190
Jan 13, 20214250001193125-21-008184
Jan 12, 20214250001193125-21-006803